The Onchocerciasis Vaccine for Africa—TOVA—Initiative

2015/01/29 by Peter J. Hotez, María Elena Bottazzi, Bin Zhan +5 · 1 citation
Environmental Science · Immunology and Microbiology · Medicine · #Distribution (mathematics) #Economic growth #Environmental health #Environmental protection #General partnership #Geography #Immunology #Ivermectin #Mass drug administration #Medicine #Neglected tropical diseases #Onchocerciasis #Parasite Biology and Host Interactions #Parasites and Host Interactions #Parasitic Diseases Research and Treatment #Political science #Population #Public health #Socioeconomics #Veterinary medicine

paper · pdf · doi:10.1371/journal.pntd.0003422

openalex publication_date 2015/01/29 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Abstract

New supportive health intervention technologies, including a vaccine, may be required in order to achieve onchocerciasis (river blindness) elimination targets. A new transatlantic partnership has been established to develop and test an onchocerciasis vaccine for Africa.

Cited by

• Onchocerciasis [wikipedia]

Related

• The BRILLIANT HIV Vaccine Consortium: Unfunded but not undone
• A landscape analysis of the vaccine ecosystem in Africa: research and development funding, clinical trials, regulation, and manufacturing readiness
• Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
• Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine
• Equitable access to pathogens and countermeasures: is the pandemic agreement's pathogen access and benefit-sharing system the answer to Africa's future health security?